{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:48:38Z","timestamp":1778730518798,"version":"3.51.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,1]]},"DOI":"10.1093\/femsyr\/fov001","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:01:13Z","timestamp":1425945673000},"source":"Crossref","is-referenced-by-count":30,"title":["Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans"],"prefix":"10.1093","volume":"15","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxiang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,3,17]]},"reference":[{"key":"key\n\t\t\t\t20171012005557_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1128\/AAC.48.4.1335-1343.2004","article-title":"Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole","volume":"48","year":"2004","journal-title":"Antimicrob Agents Ch"},{"key":"key\n\t\t\t\t20171012005557_bib2","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1128\/JCM.37.10.3332-3337.1999","article-title":"Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans","volume":"37","year":"1999","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171012005557_bib3","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/infdis\/167.5.1247","article-title":"Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980\u20131990. National Nosocomial Infections Surveillance System","volume":"167","year":"1993","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171012005557_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis","volume":"301","year":"1979","journal-title":"New Engl J Med"},{"key":"key\n\t\t\t\t20171012005557_bib5","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1099\/00221287-146-11-2743","article-title":"A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole","volume":"146","year":"2000","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20171012005557_bib6","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1248\/bpb.b12-00511","article-title":"Retigeric acid B enhances the efficacy of azoles combating the virulence and biofilm formation of Candida albicans","volume":"35","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"key\n\t\t\t\t20171012005557_bib7","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/AAC.00959-10","article-title":"Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells","volume":"55","year":"2011","journal-title":"Antimicrob Agents Ch"},{"key":"key\n\t\t\t\t20171012005557_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/AAC.40.2.419","article-title":"Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance","volume":"40","year":"1996","journal-title":"Antimicrob Agents Ch"},{"key":"key\n\t\t\t\t20171012005557_bib9","volume-title":"Reference Methods for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard","author":"CLSI","year":"2008","edition":"3rd edn"},{"key":"key\n\t\t\t\t20171012005557_bib10","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1126\/science.1118370","article-title":"Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi","volume":"309","year":"2005","journal-title":"Science"},{"key":"key\n\t\t\t\t20171012005557_bib11","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1021\/cr900019j","article-title":"Impact of natural products on developing new anti-cancer agents","volume":"109","year":"2009","journal-title":"Chem Rev"},{"key":"key\n\t\t\t\t20171012005557_bib12","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/AAC.00463-08","article-title":"ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates","volume":"52","year":"2008","journal-title":"Antimicrob Agents Ch"},{"key":"key\n\t\t\t\t20171012005557_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","year":"2004","journal-title":"Antimicrob Agents Ch"},{"key":"key\n\t\t\t\t20171012005557_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/33.1.2578146","article-title":"An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide","volume":"33","year":"1985","journal-title":"J Histochem Cytochem"},{"key":"key\n\t\t\t\t20171012005557_bib15","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1128\/AAC.00684-06","article-title":"Candida albicans biofilms produce antifungal-tolerant persister cells","volume":"50","year":"2006","journal-title":"Antimicrob Agents Ch"},{"key":"key\n\t\t\t\t20171012005557_bib16","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1086\/344658","article-title":"Antifungal drug resistance","volume":"36","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012005557_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","article-title":"Mechanisms of biofilm resistance to antimicrobial agents","volume":"9","year":"2001","journal-title":"Trends Microbiol"},{"key":"key\n\t\t\t\t20171012005557_bib19","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1128\/AAC.00303-10","article-title":"A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14\u03b1-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B","volume":"54","year":"2010","journal-title":"Antimicrobial Agents Ch"},{"key":"key\n\t\t\t\t20171012005557_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajic.2009.06.014","article-title":"Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections","volume":"38","year":"2010","journal-title":"Am J Infect Control"},{"key":"key\n\t\t\t\t20171012005557_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fgb.2009.08.002","article-title":"Regulation of multidrug resistance in pathogenic fungi","volume":"47","year":"2010","journal-title":"Fungal Genet Biol"},{"key":"key\n\t\t\t\t20171012005557_bib22","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans","volume":"3","year":"2007","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20171012005557_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/CMR.18.1.163-194.2005","article-title":"Combination treatment of invasive fungal infections","volume":"18","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20171012005557_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/jac\/46.2.338","article-title":"Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis","volume":"46","year":"2000","journal-title":"J Antimicrob Chemoth"},{"key":"key\n\t\t\t\t20171012005557_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/10408410903241436","article-title":"Our current understanding of fungal biofilms","volume":"35","year":"2009","journal-title":"Crit Rev Microbiol"},{"key":"key\n\t\t\t\t20171012005557_bib25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/501795","article-title":"Nosocomial infections in combined medical-surgical intensive care units in the United States","volume":"21","year":"2000","journal-title":"Infect Cont Hosp Ep"},{"key":"key\n\t\t\t\t20171012005557_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0732-8893(02)00361-9","article-title":"Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods","volume":"43","year":"2002","journal-title":"Diagn Micr Infect Dis"},{"key":"key\n\t\t\t\t20171012005557_bib27","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1128\/AAC.40.10.2300","article-title":"Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors","volume":"40","year":"1996","journal-title":"Antimicrob Agents Ch"},{"key":"key\n\t\t\t\t20171012005557_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrmicro2636","article-title":"Growth of Candida albicans hyphae","volume":"9","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20171012005557_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2672.2009.04429.x","article-title":"Synergistic mechanisms of retigeric acid B and azoles against Candida albicans","volume":"108","year":"2010","journal-title":"J Appl Microbiol"},{"key":"key\n\t\t\t\t20171012005557_bib30","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/AAC.00940-08","article-title":"In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans","volume":"53","year":"2009","journal-title":"Antimicrob Agents Ch"},{"key":"key\n\t\t\t\t20171012005557_bib31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01397-07","article-title":"Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms","volume":"52","year":"2008","journal-title":"Antimicrob Agents Ch"},{"key":"key\n\t\t\t\t20171012005557_bib32","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1745-7254.2008.00900.x","article-title":"Effect of plagiochin E, an antifungal macrocyclic bis (bibenzyl), on cell wall chitin synthesis in Candida albicans","volume":"29","year":"2008","journal-title":"Acta Pharm Sinic"},{"key":"key\n\t\t\t\t20171012005557_bib33","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1128\/AAC.06082-11","article-title":"In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis","volume":"56","year":"2012","journal-title":"Antimicrob Agents Ch"}],"container-title":["FEMS Yeast Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femsyr\/article-pdf\/15\/2\/fov001\/10746205\/fov001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T17:05:56Z","timestamp":1598807156000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/femsyr\/article\/doi\/10.1093\/femsyr\/fov001\/536584\/Synergistic-and-drugresistant-reversing-effects-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,1]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,3,17]]},"published-print":{"date-parts":[[2015,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/femsyr\/fov001","relation":{},"ISSN":["1567-1356","1567-1364"],"issn-type":[{"value":"1567-1356","type":"print"},{"value":"1567-1364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,1]]}}}